At Lankenau Heart Institute located just outside of Philadelphia, we approach coronary artery disease with preventive strategies along with medication therapy and the least invasive yet most sophisticated interventional and surgical techniques available. We routinely perform successful, minimally invasive heart bypass surgery on high-risk patients.
Robotic-assisted surgery enables us to perform complex procedures such as coronary artery bypass graft (CABG) and hybrid coronary revascularization through a 1.5” incision, alleviating the need for risky, open-heart procedures and enabling our surgeons to achieve steady precision in microscopic areas. Our non-surgical interventional treatments include diagnostic cardiac catheterization and percutaneous coronary intervention (angioplasty). Performed through the wrist (radial artery) or the leg (femoral artery), these procedures allow us to identify exactly where your blockages are and to open narrowed arteries.
The way to a healthier heart is with healthier habits. Our multidisciplinary team works with you around related health issues such as weight management and diabetes. Our goal is to provide you with nutritional information and support you need to implement new behaviors that can reduce risks associated with coronary artery disease.
To get a broad spectrum view of how cholesterol is working in your body we rely on advanced lipid testing, a way of assessing your unique lipid profile and a more reliable method than standard testing for understanding your body’s cholesterol-related risk. Advanced lipid tests can help us more accurately guide your treatment options and decisions.
We also employ new lipid drugs called PCSK9 inhibitors, which act against a protein that prevents the body from effectively removing LDL (“bad”) cholesterol from the body. PCSK9 inhibitors are able to lower cholesterol with or without statins, which have typically been used to manage cholesterol but may have significant side effects and may not sufficiently reduced LDL for some patients.
We are also the first and only system in the Philadelphia region to offer HeartFlow FFRct (fractional flow reserve) Analysis, a noninvasive diagnostic test that is used along with a cardiac CT scan to create a 3D image of your coronary arteries. The analysis allows your doctor to see the arteries with greater clarity and understanding, which helps guide treatment decisions and may prevent you from having invasive or unnecessary tests.
Our success with minimally invasive heart surgery and the adoption of new technologies is revolutionizing our thinking about the treatment of coronary artery disease. In the area of interventional cardiology we have a long-standing reputation of excellence in cardiac catheterization. Our team performs more than 5,400 cardiac catheterizations annually, including both diagnostic studies and catheter-based treatments.
Other distinguishing features of our coronary artery disease program include:
Located in the suburbs of Philadelphia, Lankenau Heart Institute attracts patients from around the globe.
Main Line Health uses clinical trials to help prevent, diagnose and treat the full range of heart and vascular conditions. Learn more about the cardiovascular clinical trials currently being offered by our renowned cardiologists and heart and vascular surgeons.
Our multidisciplinary team of cardiac specialists, including physicians, nurses and dietitians, work together to secure a prompt diagnosis, identify appropriate treatment options, and facilitate long-term, follow-up care.
Lankenau Heart Institute cardiologists with expertise in cancer-related heart problems are working with oncology colleagues across Main Line Health to coordinate cancer treatment with heart care. Main Line Health Cardio-Oncology Program is devoted to protecting heart health after a cancer diagnosis.
We approach coronary artery disease with preventive strategies along with medication therapy and the least invasive yet most sophisticated surgical techniques available.
Our team evaluates your risk factors and uses the latest treatment advances and novel techniques to restore blood flow throughout your body and to minimize your risk for heart attack, stroke and amputation.
Our surgeons perform hundreds of procedures to open blocked arteries and restore healthy blood flow with traditional open surgery as well as minimally invasive and endovascular interventions.
Complex aortic disease treatment at Lankenau Heart Institute begins with the experience of an exceptional team of aortic wellness specialists, state-of-the-art diagnostic technology, and a comprehensive array of medical and minimally invasive surgical treatment options.
Women's Heart Initiative is a comprehensive health care program specifically dedicated to education and awareness about women's heart care.
The cardiologists and cardiovascular surgeons at Main Line Health work together to improve the detection and prevention of heart disease with the latest treatment options.
